Document Detail

Liposomal formulations for inhalation.
MedLine Citation:
PMID:  23919478     Owner:  NLM     Status:  In-Data-Review    
No marketed inhaled products currently use sustained release formulations such as liposomes to enhance drug disposition in the lung, but that may soon change. This review focuses on the interaction between liposomal formulations and the inhalation technology used to deliver them as aerosols. There have been a number of dated reviews evaluating nebulization of liposomes. While the information they shared is still accurate, this paper incorporates data from more recent publications to review the factors that affect aerosol performance. Recent reviews have comprehensively covered the development of dry powder liposomes for aerosolization and only the key aspects of those technologies will be summarized. There are now at least two inhaled liposomal products in late-stage clinical development: ARIKACE(®) (Insmed, NJ, USA), a liposomal amikacin, and Pulmaquin™ (Aradigm Corp., CA, USA), a liposomal ciprofloxacin, both of which treat a variety of patient populations with lung infections. This review also highlights the safety of inhaled liposomes and summarizes the clinical experience with liposomal formulations for pulmonary application.
David Cipolla; Igor Gonda; Hak-Kim Chan
Related Documents :
3566498 - Post-traumatic spinal stenosis.
15326468 - Spinal cord infarction due to a self-inflicted needle stick injury.
535838 - First autopsy report of a multiple sclerosis case in hokuriku district of japan.
8943598 - Acute stridor as a presentation of bilateral abductor vocal cord paralysis.
6193858 - Malignant lymphoma of mucosa-associated lymphoid tissue. a distinctive type of b-cell l...
18539678 - Osteochondrosis juvenilis of the medial malleolar epiphysis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic delivery     Volume:  4     ISSN:  2041-5990     ISO Abbreviation:  Ther Deliv     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-08-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101538870     Medline TA:  Ther Deliv     Country:  England    
Other Details:
Languages:  eng     Pagination:  1047-72     Citation Subset:  IM    
Department of Pharmacy, Pharmacy & Bank Building A15, The University of Sydney, NSW 2006 Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mechanisms of absorption and elimination of drugs administered by inhalation.
Next Document:  American crows as carriers of vancomycin-resistant enterococci with vanA gene.